ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Alkermes, Biogen Announce FDA Acceptance of Diroximel Fumarate NDA
February 27, 2019Alkermes and Biogen announced the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for diroximel fumarate (BIIB098) ..... -
Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis
December 26, 2018Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) today announced that Alkermes has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for .... -
Alkermes, Biogen Submits NDA for Diroximel Fumarate
December 18, 2018Alkermes and Biogen announced Alkermes has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for diroximel fumarate (BIIB098).....
Pharma Sources Insight January 2025
